Skip to main content
SpringerLink
Log in

Cirrhosis and Hepatocellular Carcinoma

  • Chapter
  • First Online:
Cross-Sectional Imaging of the Abdomen and Pelvis

  • 2833 Accesses

Abstract

In this chapter, we illustrate the imaging features of cirrhosis and the progression to hepatocellular carcinoma using an algorithmic approach. We will then discuss the various imaging features of hepatocellular carcinoma according to the LI-RADS (Liver Imaging-Reporting and Data Systems) criteria.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hussein SM, et al. Cirrhosis and lesion characterization at MR imaging. Radiographics. 2009;29:1637–52.

    Article  Google Scholar 

  2. Federle et al. Diagnostic imaging: abdomen. Amirsys; Salt Lake City, Utah 2009.

    Google Scholar 

  3. Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, editor. The liver and portal hypertension. Philadelphia: Saunders; 1964. p. 50–64.

    Google Scholar 

  4. Wiegand J, Berg T. The etiology, diagnosis and prevention of liver cirrhosis—part 1 of a series on liver cirrhosis. Dtsch Arztebl Int. 2013;110(6):85–91.

    PubMed  PubMed Central  Google Scholar 

  5. Lee JM, et al. Recent advances in CT and MR imaging for hepatocellular carcinoma. Liver Cancer. 2012;1(1):22–40.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hanna RF, et al. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics. 2008;28(3):747–69.

    Article  PubMed  Google Scholar 

  7. Haimerl M, et al. Added value of Gd-EOB-DTPA-enhanced hepatobiliary phase MR imaging in the evaluation of focal solid hepatic lesions. BMC Med Imaging. 2013;13:41.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ito K, et al. Enlargement of the hilar periportal space: a sign of early cirrhosis at MR imaging. J Magn Reson Imaging. 2000;11:136–40.

    Article  CAS  PubMed  Google Scholar 

  9. Liu CH, et al. Esophageal varices: noninvasive diagnosis with duplex Doppler US in patients with compensated cirrhosis. Radiology. 2008;248(1):132–9.

    Article  PubMed  Google Scholar 

  10. Ishikawa T, et al. CT-maximum intensity projection is a clinically useful modality for the detection of gastric varices. World J Gastroenterol. 2005;11(47):7515–9.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Cho KC, et al. Varices in portal hypertension: evaluation with CT. Radiographics. 1995;15(3):609–22.

    Article  CAS  PubMed  Google Scholar 

  12. Efremidis SC, Hytiroglou P. The multistep process of hepatocarcinogenesis in cirrhosis with imaging correlation. Eur Radiol. 2002;12(4):753–64.

    Article  PubMed  Google Scholar 

  13. Coleman WB. Mechanisms of human hepatocarcinogenesis. Curr Mol Med. 2003;3(6):573–88.

    Article  CAS  PubMed  Google Scholar 

  14. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology. 1995; 22(3): 983–993.

    Article  Google Scholar 

  15. Willatt JM, et al. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology. 2008;247(2):311–30. Liver.

    Article  PubMed  Google Scholar 

  16. Dodd 3rd GD, et al. Spectrum of imaging findings of the liver in end-stage cirrhosis: part I, gross morphology and diffuse abnormalities. AJR Am J Roentgenol. 1999;173(4):1031–6.

    Article  PubMed  Google Scholar 

  17. Lim JH, Kim EY, Lee WJ, et al. Regenerative nodules in liver cirrhosis: findings at CT during arterial portography and CT hepatic arteriography with histopathologic correlation. Radiology. 1999;210(2):451–8.

    Article  CAS  PubMed  Google Scholar 

  18. Baron RL, Peterson MS. Screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls. Radiographics. 2001;21(Spec Issue):S117–32.

    Article  PubMed  Google Scholar 

  19. Freeny PC, Grossholz M, Kaakaji K, Schmiedl UP. Significance of hyperattenuating and contrast-enhancing hepatic nodules detected in the cirrhotic liver during arterial phase helical CT in pre-liver transplant patients: radiologic-histopathologic correlation of explanted livers. Abdom Imaging. 2003;28(3):333–46.

    Article  CAS  PubMed  Google Scholar 

  20. Krinsky GA, Israel G. Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR imaging: frequency in cirrhotic patients undergoing transplantation. AJR Am J Roentgenol. 2003;180(4):1023–7.

    Article  PubMed  Google Scholar 

  21. Mathieu D, Paret M, Mahfouz AE, et al. Hyperintense benign liver lesions on spin-echo T1-weighted MR images: pathologic correlations. Abdom Imaging. 1997;22(4):410–7.

    Article  CAS  PubMed  Google Scholar 

  22. Zhang J, Krinsky GA. Iron-containing nodules of cirrhosis. NMR Biomed. 2004;17(7):459–64.

    Article  PubMed  Google Scholar 

  23. Krinsky GA, Lee VS, Nguyen MT, et al. Siderotic nodules in the cirrhotic liver at MR imaging with explant correlation: no increased frequency of dysplastic nodules and hepatocellular carcinoma. Radiology. 2001;218(1):47–53.

    Article  CAS  PubMed  Google Scholar 

  24. Ito K, Mitchell DG, Gabata T, et al. Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging. Radiology. 1999;212(1):235–40.

    Article  CAS  PubMed  Google Scholar 

  25. Theise ND, Schwartz M, Milller C, Thung SN. Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis. Hepatology. 1992;16(4):949–55.

    Article  CAS  PubMed  Google Scholar 

  26. Putative precancerous lesions. In: Ishak KG, Goodman ZD, Stocker JT. Atlas of tumor pathology: tumors of the liver and intrahepatic bile ducts. Third series, fascicle 31. Armed Forces Institute of Pathology, Washington, DC 2001; 185.

    Google Scholar 

  27. Takayama T, Makuuchi M, Hirohashi S, et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet. 1990;336(8724):1150–3.

    Article  CAS  PubMed  Google Scholar 

  28. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol. 1991;22(2):172–8.

    Article  CAS  PubMed  Google Scholar 

  29. Efremidis SC, Hytiroglou P, Matsui O. Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges. Eur Radiol. 2007;17(11):2969–82.

    Article  PubMed  Google Scholar 

  30. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology. 1991;178(2):493–7.

    Article  CAS  PubMed  Google Scholar 

  31. Choi BI, Han JK, Hong SH, et al. Dysplastic nodules of the liver: imaging findings. Abdom Imaging. 1999;24(3):250–7.

    Article  CAS  PubMed  Google Scholar 

  32. Hayashi M, Matsui O, Ueda K, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol. 1999;172(4):969–76.

    Article  CAS  PubMed  Google Scholar 

  33. Krinsky GA, Theise ND, Rofsky NM, Mizrachi H, Tepperman LW, Weinreb JC. Dysplastic nodules in cirrhotic liver: arterial phase enhancement at CT and MR imaging—a case report. Radiology. 1998;209(2):461–4.

    Article  CAS  PubMed  Google Scholar 

  34. Seki S, Sakaguchi H, Kitada T, et al. Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study. Clin Cancer Res. 2000;6(9):3469–73.

    CAS  PubMed  Google Scholar 

  35. Farmer DG, et al. Current treatment modalities for hepatocellular carcinoma. Ann Surg. 1994;219:236–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Mitchell DG, Rubin R, Siegelman ES, Burk Jr DL, Rifkin MD. Hepatocellular carcinoma within siderotic regenerative nodules: appearance as anodule within a nodule on MR images. Radiology. 1991;178(1):101–3.

    Article  CAS  PubMed  Google Scholar 

  37. Goshima S, Kanematsu M, Matsuo M, et al. Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2004;20(2):250–5.

    Article  PubMed  Google Scholar 

  38. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94(2):153–6.

    Article  CAS  PubMed  Google Scholar 

  39. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127(5 suppl 1):S27–34.

    Article  PubMed  Google Scholar 

  40. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340(10):745–50.

    Article  CAS  PubMed  Google Scholar 

  41. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362(9399):1907–17.

    Article  PubMed  Google Scholar 

  42. Liaw YF, Tai DI, Chu CM, et al. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis: a prospective study. Gastroenterology. 1986;90(2):263–7.

    Article  CAS  PubMed  Google Scholar 

  43. Bosch FX, Ribes J, Dı’az M, Cle’ries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127(5 suppl1):S5–16.

    Article  PubMed  Google Scholar 

  44. Thompson Coon J, Rogers G, Hewson P, et al. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess. 2007;11(34):1–206.

    Article  CAS  PubMed  Google Scholar 

  45. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 2002;36(6):1349–54.

    Article  PubMed  Google Scholar 

  46. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005;25(2):181–200.

    Article  PubMed  Google Scholar 

  47. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208–36.

    Article  PubMed  Google Scholar 

  48. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130(7):417–22.

    Article  PubMed  Google Scholar 

  49. Colli A, Fraquelli M, Casazza G, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol. 2006;101(3):513–23.

    Article  CAS  PubMed  Google Scholar 

  50. Jeong YY, et al. Hepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: imaging spectrum and pitfalls in cirrhosis-related nodules. AJR Am J Roentgenol. 2005;185:1024–32.

    Article  PubMed  Google Scholar 

  51. Elsayes KM, et al. Focal hepatic lesions: diagnostic value of enhancement pattern approach with contrast enhanced 3D gradient-Echo MR imaging. Radiographics. 2005;25:1299–320.

    Article  PubMed  Google Scholar 

  52. Hussain SM, Zondervan PE, Ijzermans JN, Schalm SW, de Man RA, Krestin GP. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics. 2002;22(5):1023–36.

    Article  PubMed  Google Scholar 

  53. Kadoya M, Matsui O, Takashima T, et al. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology. 1992;183:819–25.

    Article  CAS  PubMed  Google Scholar 

  54. Hussain SM, Semelka RC, Mitchell DG. MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am. 2002;10:31–52.

    Article  PubMed  Google Scholar 

  55. Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE. Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992–2008. Hepatology. 2012;55(2):476–82.

    Article  PubMed  Google Scholar 

  56. American College of Radiology. Liver Imaging Reporting and Data System version 2013.1. Accessed Mar 2014, from http://www.acr.org/Quality-Safety/Resources/LIRADS/.

  57. Sharma P, Kalb B, Kitajima HD, et al. Optimization of single injection liver arterial phase gadolinium enhanced MRI using bolus track real-time imaging. J Magn Reson Imaging. 2011;33(1):110–1.

    Article  PubMed  Google Scholar 

  58. Dixon AK. The impact of medical imaging on the physician’s diagnostic and therapeutic thinking. Eur Radiol. 1998;8(3):488–90.

    Article  CAS  PubMed  Google Scholar 

  59. Ayuso C, Rimola J, García-Criado A. Imaging of HCC. Abdom Imaging. 2012;37(2):215–30.

    Article  PubMed  Google Scholar 

  60. Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl. 2005;11(3):281–9.

    Article  PubMed  Google Scholar 

  61. Sherman M. The radiological diagnosis of hepatocellular carcinoma. Am J Gastroenterol. 2010;105(3):610–2.

    Article  PubMed  Google Scholar 

  62. Purysko AS, et al. LI-Rads: A case based review of the new categorization of liver findings in patients with end stage liver disease. Radiographics. 2012;32:1977–95.

    Article  PubMed  Google Scholar 

  63. Rimola J, et al. Non-invasive diagnosis of hepatocellular carcinoma </=2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. J Hepatol. 2012;56(6):1317–23. June.

    Article  PubMed  Google Scholar 

  64. Fowler KJ, Brown JJ, Narra VR. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis. Hepatology. 2011;54(6):2227–37.

    Article  PubMed  Google Scholar 

  65. Ueda K, Matsui O, Kawamori Y, et al. Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography. Radiology. 1998;206(1):161–6.

    Article  CAS  PubMed  Google Scholar 

  66. Dodd 3rd GD, Memel DS, Baron RL, Eichner L, Santiguida LA. Portal vein thrombosis in patients with cirrhosis: does sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus? AJR Am J Roentgenol. 1995;165(3):573–7.

    Article  PubMed  Google Scholar 

  67. Sakata J, Shirai Y, Wakai T, Kaneko K, Nagahashi M, Hatakeyama K. Preoperative predictors of vascular invasion in hepatocellular carcinoma. Eur J Surg Oncol. 2008;34(8):900–5.

    Article  CAS  PubMed  Google Scholar 

  68. Brancatelli G, Baron RL, Peterson MS, Marsh W. Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation. AJR Am J Roentgenol. 2003;180(4):1007–14.

    Article  PubMed  Google Scholar 

  69. Jeong YY, Mitchell DG, Kamishima T. Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol. 2002;178(6):1327–34.

    Article  PubMed  Google Scholar 

  70. Colagrande S, Centi N, Galdiero R, Ragozzino A. Transient hepatic intensity differences. 1. Those associated with focal lesions. AJR Am J Roentgenol. 2007;188(1):154–9.

    Article  PubMed  Google Scholar 

  71. OPTN/UNOS Liver.and Intestinal Organ Transplantation Committee. Report to the Board of Directors. Available at: http://optn.transplant.hrsa.gov/

  72. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693–9.

    Article  CAS  PubMed  Google Scholar 

  73. Wald C, et al. New OPTN/UNOS policy for liver transplantation allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology. 2013;266(2):376–82.

    Article  PubMed  Google Scholar 

  74. Craig JR, Peters RL, Edmondson HA, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer. 1980;46:372–37.

    Article  CAS  PubMed  Google Scholar 

  75. Berman MA, Burnham JA, Sheahan DG. Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol. 1988;19:784–94.

    Article  CAS  PubMed  Google Scholar 

  76. Epstein BE, Pajak TF, Haulk TL, Herpst JM, Order SE, Abrams RA. Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history. Am J Clin Oncol. 1999;22:22–8.

    Article  CAS  PubMed  Google Scholar 

  77. Ganeshan D, et al. Imaging features of fibrolamellar hepatocellular carcinoma. Am J Roentgenol. 2014;202(3):544–52.

    Article  Google Scholar 

  78. Ichikawa T, Federle MP, Grazioli L, Marsh W. Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging. Radiology. 2000;217:145–51.

    Article  CAS  PubMed  Google Scholar 

  79. Ichikawa T, Federle MP, Grazioli L, Madariaga J, Nalesnik M, Marsh W. Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology. 1999;213(2):352–61.

    Article  CAS  PubMed  Google Scholar 

  80. Blachar A, Federle MP, Ferris JV, et al. Radiologists’ performance in the diagnosis of liver tumors with central scars by using specific CT criteria. Radiology. 2002;223:532–9.

    Article  PubMed  Google Scholar 

  81. Bartolozzi C, Battaglia V, Bozzi E. HCC diagnosis with liver-specific MRI: close to histopathology. Dig Dis. 2009;27:125–30.

    Article  PubMed  Google Scholar 

  82. Ringe KI, Husarik DB, Sirlin CB, Merkle EM. Gadoxetate disodium–enhanced MRI of the liver. Part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol. 2010;195:13–2.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Ravinder S. Legha MD

  2. Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Khaled M. Elsayes MD

  3. Department of Diagnostic Radiology, University of Michigan Health Center, Ann Arbor, MI, USA

    Hero K. Hussain MD

Authors
  1. Ravinder S. Legha MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Khaled M. Elsayes MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hero K. Hussain MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ravinder S. Legha MD .

Editor information

Editors and Affiliations

  1. Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Khaled M. Elsayes MD

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Legha, R.S., Elsayes, K.M., Hussain, H.K. (2015). Cirrhosis and Hepatocellular Carcinoma. In: Elsayes, K.M. (eds) Cross-Sectional Imaging of the Abdomen and Pelvis. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1884-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1884-3_3

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1883-6

  • Online ISBN: 978-1-4939-1884-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation